{"nct_id":"NCT02451930","title":"A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC","status":"COMPLETED","status_verified_date":"2019-10-01","start_date":"2015-09-04","start_date_type":"ACTUAL","primary_completion_date":"2017-01-26","primary_completion_date_type":"ACTUAL","completion_date":"2019-09-17","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}